203 related articles for article (PubMed ID: 26067856)
21. Nuclear receptor profiling of ovarian granulosa cell tumors.
Alexiadis M; Eriksson N; Jamieson S; Davis M; Drummond AE; Chu S; Clyne CD; Muscat GE; Fuller PJ
Horm Cancer; 2011 Jun; 2(3):157-69. PubMed ID: 21761343
[TBL] [Abstract][Full Text] [Related]
22. The molecular mechanism of ovarian granulosa cell tumors.
Li J; Bao R; Peng S; Zhang C
J Ovarian Res; 2018 Feb; 11(1):13. PubMed ID: 29409506
[TBL] [Abstract][Full Text] [Related]
23. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
24. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
Puvanenthiran S; Essapen S; Seddon AM; Modjtahedi H
Int J Oncol; 2016 Nov; 49(5):1825-1838. PubMed ID: 27599579
[TBL] [Abstract][Full Text] [Related]
25. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Chu S; Nishi Y; Yanase T; Nawata H; Fuller PJ
Mol Endocrinol; 2004 Aug; 18(8):1919-28. PubMed ID: 15155785
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
Hazama Y; Tsujioka T; Kitanaka A; Tohyama K; Shimoya K
PLoS One; 2022; 17(7):e0271245. PubMed ID: 35802681
[TBL] [Abstract][Full Text] [Related]
27. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40.
Furger C; Fiddes RJ; Quinn DI; Bova RJ; Daly RJ; Sutherland RL
Cancer Res; 1998 May; 58(9):1773-8. PubMed ID: 9581810
[TBL] [Abstract][Full Text] [Related]
28. Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cells.
Trisdale SK; Schwab NM; Hou X; Davis JS; Townson DH
J Ovarian Res; 2016 Feb; 9():8. PubMed ID: 26911253
[TBL] [Abstract][Full Text] [Related]
29. Persistent endocrine-disrupting chemicals found in human follicular fluid stimulate IGF1 secretion by adult ovarian granulosa cell tumor spheroids and thereby increase proliferation of non-cancer ovarian granulosa cells.
Gogola J; Hoffmann M; Ptak A
Toxicol In Vitro; 2020 Jun; 65():104769. PubMed ID: 31923581
[TBL] [Abstract][Full Text] [Related]
30. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
32. Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells.
Haltia UM; Andersson N; Yadav B; Färkkilä A; Kulesskiy E; Kankainen M; Tang J; Bützow R; Riska A; Leminen A; Heikinheimo M; Kallioniemi O; Unkila-Kallio L; Wennerberg K; Aittokallio T; Anttonen M
Gynecol Oncol; 2017 Mar; 144(3):621-630. PubMed ID: 28104295
[TBL] [Abstract][Full Text] [Related]
33. Estrogen regulates forkhead transcription factor 2 to promote apoptosis of human ovarian granulosa-like tumor cells.
Wu J; Miao C; Lv X; Zhang Y; Li Y; Wang D
J Steroid Biochem Mol Biol; 2019 Nov; 194():105418. PubMed ID: 31376461
[TBL] [Abstract][Full Text] [Related]
34. New small-molecule compound Hu-17 inhibits estrogen biosynthesis by aromatase in human ovarian granulosa cancer cells.
Xi Y; Liu J; Wang H; Li S; Yi Y; Du Y
Cancer Med; 2020 Dec; 9(23):9081-9095. PubMed ID: 33002342
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis and differentiation induced by staurosporine in granulosa tumor cells is coupled with activation of JNK and suppression of p38 MAPK.
Zhang H; Vollmer M; De Geyter M; Dürrenberger M; De Geyter C
Int J Oncol; 2005 Jun; 26(6):1575-80. PubMed ID: 15870872
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth.
Rico C; Laguë MN; Lefèvre P; Tsoi M; Dodelet-Devillers A; Kumar V; Lapointe E; Paquet M; Nadeau MÈ; Boerboom D
Carcinogenesis; 2012 Nov; 33(11):2283-92. PubMed ID: 22871496
[TBL] [Abstract][Full Text] [Related]
37. GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.
Kyrönlahti A; Kauppinen M; Lind E; Unkila-Kallio L; Butzow R; Klefström J; Wilson DB; Anttonen M; Heikinheimo M
Endocr Relat Cancer; 2010 Sep; 17(3):709-17. PubMed ID: 20554787
[TBL] [Abstract][Full Text] [Related]
38. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
[TBL] [Abstract][Full Text] [Related]
39. Targeting XIAP and PPARγ in Granulosa Cell Tumors Alters Metabolic Signaling.
Leung DTH; Rainczuk A; Nguyen T; Stephens A; Silke J; Fuller PJ; Chu S
J Proteome Res; 2019 Apr; 18(4):1691-1702. PubMed ID: 30706710
[TBL] [Abstract][Full Text] [Related]
40. Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
Crosley P; Farkkila A; Jenner AL; Burlot C; Cardinal O; Potts KG; Agopsowicz K; Pihlajoki M; Heikinheimo M; Craig M; Fu Y; Hitt MM
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
